Unbiased Analysis of Today's Healthcare Issues

Free Money for Amgen

The language buried in Section 632 of the [American Taxpayer Relief] law delays a set of Medicare price restraints on a class of drugs that includes Sensipar, a lucrative Amgen pill used by kidney dialysis patients. The provision gives Amgen an additional two years to sell Sensipar without government controls. The news was so welcome […]

Read the rest of this entry »